Breaking News

You are here » Indian-Commodity  :  Commodities  :  Chana  :  Chana futures trade lower on sluggish demand

27-Sep2014

Chana futures trade lower on sluggish demand

Chana futures traded lower on NCDEX on account of sluggish demand in the spot markets amidst hopes of higher output from the major producing belts. However, news of the withdrawal of monsoon rains from some parts of the western region, capped some losses in chana prices to some extent.

The contract for October delivery was trading at Rs 2762.00, down by 1.15% or Rs 32.00 from its previous closing of Rs 2794.00. The open interest of the contract stood at 104100 lots.

The contract for November delivery was trading at Rs 2853.00, down by 1.11% or Rs 32.00 from its previous closing of Rs 2885.00. The open interest of the contract stood at 97370 lots on NCDEX.


Related News

View all news

Government imposes 30% import duty on Chana, Masoor

Government has decided to impose 30% import duty on Chana (Chickpeas) and Masoor (Lentils), with immediate effect. The production of Chana (Chickpeas) and Masoor (Lentils) are expected to be high during......

NCDEX reports Rs 91 crore turnover in chana contract on re-launch day

National Commodity & Derivatives Exchange (NCDEX), an online agri-commodity exchange has registered a turnover of Rs 91 crore on the first day of the re-launch of chana (pulses) contracts. The......

NCDEX receives SEBI's nod to re-launch chana futures

National Commodity & Derivatives Exchange (NCDEX), an online agri-commodity exchange will re-launch the chana futures contract expiring in the months of September 2017, October 2017 and November......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......